Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: A randomised controlled double-blind multicentre trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 120, Issue 1, 2013, Pages 50-57

  Serra, V ^a   Perales, A ^a,b   Meseguer, J ^c   Parrilla, J J ^c   Lara, C ^a   Bellver, J ^a   Grifol, R ^b   Alcover, I ^d   Sala, M ^e   Martinez Escoriza J C ^e   Pellicer, A ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^d HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Multiple pregnancy; prematurity; prevention; progestogens

Indexed keywords

PLACEBO; PROGESTERONE;

ADULT; ARTICLE; BIRTH RATE; CHOLESTASIS; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; EVENING DOSAGE; FEMALE; GESTATIONAL AGE; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN MORBIDITY; PERINATAL MORTALITY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TWIN PREGNANCY;

ADMINISTRATION, INTRAVAGINAL; ADULT; BIRTH WEIGHT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MEDICATION ADHERENCE; PESSARIES; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, TWIN; PREMATURE BIRTH; PROGESTERONE; PROGESTINS; SELF CARE;

EID: 84871205871     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2012.03448.x     Document Type: Article

References (31)

1. Büscher U, Horstkamp B, Wessel J, Chen FCK, Dudenhausen JW,. Frequency and significance of preterm delivery in twin pregnancies. Int J Gynaecol Obstet 2000; 69: 1-7. (Pubitemid 30173370)
2. Chauhan SP, Scardo JA, Hayes E, Abuhamad AZ, Berghella V,. Twins: prevalence, problems, and preterm births. Am J Obstet Gynecol 2010; 203: 305-15.
3. Stock S, Norman J,. Preterm and term labour in multiple pregnancies. Semin Fetal Neonatal Med 2010; 15: 336e41.
4. Keirse MJ,. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990; 97: 149-54. (Pubitemid 20134285)
5. Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH,. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007; 357: 462-9. (Pubitemid 47204875)
6. Hassan SS, Romero R, Vidyadhari D, Fusey S, Baxter JK, Khandelwal M, etal. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial. Ultrasound Obstet Gynecol 2011; 38: 18-31.
7. da Fonseca EB, Bittar RE, Carvalho MH, Zugaib M,. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419-24. (Pubitemid 36249980)
8. ACOG. ACOG Committee Opinion number 419 October 2008 (replaces no. 291, November 2003). Use of progesterone to reduce preterm birth. Obstet Gynecol 2008; 112: 963-5.
9. Meis PJ, Klebanoff M, Thom E, Dombrowski MP, Sibai B, Moawad AH, etal. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379-85. (Pubitemid 36682816)
10. Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, etal. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007; 357: 454-61. (Pubitemid 47204874)
11. Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, etal. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009; 373: 2034-40.
12. Combs CA, Garite T, Maurel K, Das A, Porto M,. Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2010; 203: 248-e1.
13. Combs CA, Garite T, Maurel K, Das A, Porto M, Obstetrix Collaborative Research Network. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2011; 204: 221.
14. Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, etal. Progesterone does not prevent preterm births in women with twins. South Med J 2009; 102: 900-4.
15. Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, etal. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17 alpha hydroxyprogesterone caproate. J Matern Fetal Neonatal Med 2010; 23: 1360-4.
16. Hartikainen-Sorri AL, Kauppila A, Tuimala R,. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56: 692-5. (Pubitemid 11216937)
17. Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A,. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011; 283: 423-9.
18. Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Hammerum MS, Mohapeloa H, etal. Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand 2009; 88: 1180-9.
19. Schulz K, Altman D, Moher D,. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8: 18.
20. Rebarber A, Istwan NB, Russo-Stieglitz K, Cleary-Goldman J, Rhea DJ, Stanziano GJ, etal. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery. Diabetes Care 2007; 30: 2277-80. (Pubitemid 47359031)
21. Benifla JL, Dumont M, Levardon M, Foucher E, Cadiot G, Crenn-Hebert C, etal. Effets de la progestérone naturelle micronisée sur le foie au cours du trosième trimestre de la grossesse. Contracept Fertil Sex 1997; 25: 165-9. (Pubitemid 27139492)
22. Magnin G, de Meeus JB, Sarfati R, Chaouchi O, Paillat A,. Cytolyse hépatique lors d'un traitement tocolytique par la progestérone naturelle micronisée. Presse Med 1996; 25: 102-5. (Pubitemid 26058094)
23. Yamada T, Nakago S, Kurachi O, Wang J, Takekida S, Matsuo H, etal. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells. Hum Reprod 2004; 19: 815-21. (Pubitemid 38456044)
24. NHS. Scottish, Reproductive, Health, Programme. Scottish Perinatal and Infant Mortality and Morbidity Report 2009. Edinburgh: NHS Quality Improvement Scotland (NHS QIS), 2011.
25. CEMACH. Confidential Enquiry into Maternal and Child Health. Perinatal Mortality 2007. London: CEMACH, 2009.
26. Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJ, etal. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies. Obstet Gynecol 2011; 118: 513-20.
27. da Fonseca EB, Bittar RE, Damiao R, Zugaib M,. Prematurity prevention: the role of progesterone. Curr Opin Obstet Gynecol 2009; 21: 142-7.
28. Klein K, Rode L, Nicolaides K, Krampl-Bettelheim E, Tabor A, Group fTP,. Vaginal micronized progesterone and the risk of preterm delivery in high-risk twin pregnancies-secondary analysis of a placebo-controlled randomized trial and metaanalysis. Ultrasound Obstet Gynecol 2011; 38: 281-7.
29. Romero R, Nicolaides K, Conde-Agudo A, Tabor A, O'Brien JM, Cetingoz E, etal. Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data. Am J Obstet Gynecol 2012; 206: 214.
30. Steinman G,. Difficulties in controlling and preventing preterm labor in multiple gestations: a clinical perspective. J Reprod Med 2010; 55: 143-6.
31. Hirota Y, Cha J, Dey SK,. Revisiting reproduction: prematurity and the puzzle of progesterone resistance. Nat Med 2010; 16: 529-31.